BHC MESILLA VALLEY HOSPITAL LLC
1. Target Overview & Investment Thesis
BHC MESILLA VALLEY HOSPITAL LLC is a 120-bed suburban community hospital in nan, NM with $25.2M in net patient revenue and a 16.8% operating margin. The hospital serves a payer mix of 3.6% Medicare, 2.1% Medicaid, and 94.4% commercial.
Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.8% to 24.2% (+736bps).
| Net Revenue HCRIS | $25.2M |
| Current EBITDA COMPUTED | $4.2M |
| Operating Margin COMPUTED | 16.8% |
| Occupancy HCRIS | 67.4% |
| Revenue / Bed COMPUTED | $210K |
| Net-to-Gross HCRIS | 27.2% |
| Distress Probability ML | 43.8% |
2. Market Context & Competitive Position
NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of 16.8% places it above the state median. Among 16 size-comparable peers (60-240 beds), the median margin is 3.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (60-240), prioritizing same-state peers. 16 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BHC MESILLA VALLEY HOSPITAL LL (Target) | NM | 120 | $25.2M | 16.8% |
| ST. VINCENT HOSPITAL | NM | 189 | $554.3M | -0.6% |
| SAN JUAN REGIONAL MEDICAL CENT | NM | 191 | $346.9M | -4.6% |
| MEMORIAL MEDICAL CENTER | NM | 199 | $322.7M | 8.7% |
| MOUNTAIN VIEW REG MED CTR | NM | 166 | $262.2M | 25.7% |
| GERALD CHAMPION REGIONAL MEDIC | NM | 66 | $245.9M | -11.6% |
| LOVELACE WOMENS HOSPITAL | NM | 162 | $198.8M | 7.9% |
| EASTERN NEW MEXICO MEDICAL CEN | NM | 120 | $117.8M | 54.3% |
| PLAINS REGIONAL MEDICAL CTR - | NM | 100 | $113.3M | -1.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $529K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $503K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $498K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $306K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $16K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.2M |
| + RCM Uplift | +$1.9M |
| Pro Forma EBITDA | $6.1M |
| Current Margin | 16.8% |
| Pro Forma Margin | 24.2% |
| WC Released (1x) | $966K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $6.5M | $46.5M | 7.13x | 48.1% |
| Base (11x exit) | 10.0x | 11.0x | $6.5M | $53.2M | 8.17x | 52.2% |
| Bull Case | 9.0x | 11.0x | $5.9M | $61.5M | 10.48x | 60.0% |
| Bull (12x exit) | 9.0x | 12.0x | $5.9M | $68.8M | 11.73x | 63.6% |
| Bear Case | 11.0x | 10.0x | $7.2M | $35.1M | 4.89x | 37.4% |
| Bear (11x exit) | 11.0x | 11.0x | $7.2M | $40.9M | 5.71x | 41.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 16 hospitals with 60-240 beds
- Same-state prioritization (n=17)
- Comp margins: P25=-3.6% / P50=3.0% / P75=8.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.